United Therapeutics Corp. (UTHR) PT Lowered to $103 at UBS
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $503.32 +1.07%
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Join SI Premium – FREE
UBS lowered its price target on United Therapeutics Corp. (NASDAQ: UTHR) to $103.00 (from $108.00) while maintaining a Sell rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SS&C Technologies Holdings, Inc. (SSNC) PT Raised to $101 at UBS on AUM Growth Potential
- Zhejiang Sanhua Intelligent Controls (002050:CH) PT Lowered to RMB51 at JPMorgan
- JPMorgan Downgrades Arafura Rare Earths (ARU:AU) to Underweight
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
